Cmbio
Grace Barker is a seasoned professional in the field of microbiome research and business development. Currently serving as the Business Development Manager at Clinical Microbiomics since March 2023, Barker previously held the position of Medical Science Liaison at ADM Protexin from September 2021 to February 2023. As a PhD student at Imperial STRATiGRAD from November 2017 to August 2021, research focused on the impact of diet on gut microbiota and colorectal cancer risk, exploring dietary supplementation as a mitigating factor. Additionally, experience includes a role as a Healthcare Scientist Assistant at Public Health England from November 2015 to May 2016 in the Department of Food, Environment and Water. Barker holds a Doctor of Philosophy in Clinical Medicine Research and a Master’s degree in Microbiome in Health and Disease from Imperial College London, as well as a Bachelor's degree in Biomedical Science from Lancaster University.
This person is not in any teams
Cmbio
Cmbio®, is at the forefront of the human, animal, and planetary health—microbiome science. Formed from the unification of industry leaders like Clinical Microbiomics, CosmosID, MS-Omics, DNASense and Microba’s Research Services, Cmbio® stands as the first global microbiome service and technology company equipped with state-of-the-art multi-omics laboratories and advanced bioinformatics. Our mission is to demystify the complex interplay of the microbiome and its vast influence on health and disease. By integrating applied AI with integrative systems biology, Cmbio® offers unparalleled insights and enterprise solutions that accelerate the pace of discovery and innovation in microbiome research. With GxP-compliant facilities and a robust, scalable software platform, Cmbio® is uniquely positioned to standardize microbiome analysis, ensuring reliability and comparability across global studies. We are committed to advancing scientific understanding and enhancing well-being across all life on our planet. Connect with Cmbio®: Explore how we're making strides in microbiome research and offering cutting-edge solutions to meet the grand challenges of health and sustainability.